GNPDA1

Glucosamine-6-phosphate deaminase 1 · P46926 · GNPDA1 on Sugi Atlas →

0 patent compounds predicted against GNPDA1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GNPDA1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) PHASE2/PHASE3COMPLETED
Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC) PHASE2COMPLETED
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy PHASE1COMPLETED
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines PHASE1COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Registry Gangliosidoses nanUNKNOWN
GNAO1 Natural History Study nanUNKNOWN
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam nanUNKNOWN
Genome Environment Microbiome and Metabolome in Autism Study nanCOMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Natural History of GACI With or Without ARHR2 or PXE nanUNKNOWN
Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) nanWITHDRAWN
Biomarker for Hypophosphatasia Disease (BioHypophos) nanWITHDRAWN
Identification and Characterization of Monogenic Diabetes nanCOMPLETED
The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line nanUNKNOWN
Developing a Management Approach for Patients With Late-Onset Pompe Disease nanACTIVE_NOT_RECRUITING
Biomarker Analysis for GBA Associated Parkinson's Disease nanUNKNOWN
Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte nanCOMPLETED
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3 nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
GSD VI and GSD IX Natural History nanRECRUITING
GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) nanCOMPLETED
Study of Skeletal Disorders and Short Stature nanCOMPLETED
Pathophysiology of Paget's Disease of Bone nanCOMPLETED
Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic nanCOMPLETED
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) nanUNKNOWN
A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GNPDA1 binder may also engage these)

ProteinNameSimilarity
Q5R8T8 1.000 Q5R8T8 →
A4FV08 1.000 A4FV08 →
Q6PA43 1.000 Q6PA43 →
Q64422 0.999 Q64422 →
A4IHW6 0.998 A4IHW6 →
O88958 0.997 O88958 →
Q8TDQ7 0.995 Q8TDQ7 →
Q9CRC9 0.993 Q9CRC9 →
Q17QL1 0.993 Q17QL1 →
Q16HW7 0.968 Q16HW7 →
Q9VMP9 0.961 Q9VMP9 →
Q29NT9 0.961 Q29NT9 →
Q1W376 0.956 Q1W376 →
Q9CZX0 0.953 Q9CZX0 →
Q9VQZ6 0.950 Q9VQZ6 →
Q7XPW5 0.950 Q7XPW5 →
Q259G4 0.950 Q259G4 →
Q1W374 0.950 Q1W374 →
Q1W377 0.949 Q1W377 →
A0A1S4A695 0.948 A0A1S4A695 →
Q1W375 0.948 Q1W375 →
A0A0U1WZ18 0.947 A0A0U1WZ18 →
Q9ZPS3 0.946 Q9ZPS3 →
P50397 0.946 P50397 →
Q07346 0.946 Q07346 →
Q503E1 0.945 Q503E1 →
P62498 0.945 P62498 →
O97556 0.945 O97556 →
Q8LPJ4 0.945 Q8LPJ4 →
Q42521 0.945 Q42521 →